The Longevity Podcast: Optimizing HealthSpan & MindSpan
Welcome to a new era of conversation—where artificial intelligence explores what it means to live longer and better. Created and guided by Dr. Trinh, The Longevity Podcast uses AI hosts to bring scientific discovery, health innovation, and human wisdom together. Through AI-driven discussions inspired by real research and medical insight, each episode reveals practical tools for optimizing your healthspan and mindspan—rooted in science, shaped by compassion.
Mind. Body. Spirit.
Powered by Science, Guided by Humanity.
The Longevity Podcast: Optimizing HealthSpan & MindSpan
Zombie Cells
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
We trace how cellular senescence turns damaged cells into “zombies” that stay alive, stop dividing, and poison nearby tissue with the SASP inflammatory cocktail. We weigh what the best human trials actually show about senolytics and why the next wave of precision therapies may matter more than today’s supplement hype.
• cellular senescence as an active stress state, not “cells getting tired”
• the Hayflick limit, telomeres, and why senescence starts as tumor suppression
• SASP as the driver of tissue damage, bystander effects, and inflammaging
• antagonistic pleiotropy and why SASP can help early-life healing
• immunosenescence as the reason senescent cells accumulate with age
• senolytics and survival pathways that keep senescent cells alive
• dasatinib plus quercetin and the logic of hit-and-run dosing
• Mayo Clinic data suggesting benefits depend on baseline senescent burden
• fisetin osteoarthritis trial and how bioavailability can erase lab promise
• senomorphics that silence SASP when cells are “load bearing”
• precision approaches like suicide gene therapy and senescence-targeted CAR-T
• the “psychoage” question of what longer healthspan does to human urgency
This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.
Never miss an episode—subscribe on your favorite podcast app!
Microscopic Rebellion And The Hype
SPEAKER_02Right now, inside your body, a microscopic rebellion is taking place. I'm totally serious. Like, as you're listening to this right now, certain cells in your tissues have suffered massive DNA damage. But instead of doing the honorable thing and just, you know, dying to make room for healthy cells, they've gone rogue.
SPEAKER_00They really have.
SPEAKER_02Right. They've raised these biological shields, locked themselves deep into your tissue, and just started actively spewing toxic sludge at their neighbors.
SPEAKER_00Aaron Powell It is a it's a genuinely terrifying biological reality when you phrase it exactly like that. But honestly, it's highly accurate.
SPEAKER_02I know, right? You've probably seen the headlines floating around. They're literally everywhere. Things like uh zombie cells in your organs or some billionaire tech bro spending millions to cure aging and live to be 150.
SPEAKER_00Aaron Powell Oh, the tech bro headlines are endless right now.
SPEAKER_02Endless. And it sounds like pure science fiction, like the plot of a bad zombie movie where the apocalypse just starts in a petri dish. But today we are cutting straight through all of that internet hype. We're going to talk about what is actually happening in your biology right this second. And trust me, the actual science is way weirder and way more fascinating than the clickbait makes it sound.
SPEAKER_00Trevor Burrus, Jr. It really is. The reality of the biology here is just it's so much more complex than, you know, take this magical biohacker pill and live forever.
SPEAKER_01Yeah.
SPEAKER_00Aging isn't just this abstract concept of time passing. You know, it's not just the calendar flipping over and your body suddenly deciding to ache. It's driven by very distinct, physical, measurable biological mechanisms. And today, we are zeroing in on one of the absolute biggest culprits, a phenomenon called cellular senescence.
SPEAKER_02Aaron Ross Powell Exactly. And that is the mission for this deep dive. We have a massive stack of sources to go through with you today. We're talking human clinical trials, real human data, not just mice out of Georgia, the country, not the state and the Mayo Clinic.
SPEAKER_00Aaron Powell The human data is where things get really interesting.
SPEAKER_02Totally. We've got biotech startup press releases, deeply dense physiological reviews, all of it. And we are going to figure out what these so-called zombie cells actually are, what these drugs called synolytics actually do, and most importantly, whether this science is actually ready for you to use, or if you're just, you know, flushing your money down the toilet, buying expensive powders online.
What Cellular Senescence Really Is
SPEAKER_00Which, spoiler alert, a massive amount of people are currently doing. But I think before we even touch on the drugs that supposedly clear these things out, we really have to ground this in the biology. We need to unpack what a zombie cell actually is. Because your body doesn't just spontaneously generate monsters to ruin your life. There is a deeply ingrained evolutionary reason they exist. Aaron Powell Right.
SPEAKER_02So let's get into it. Because I hear a term like cellular senescence, and my brain just defaults to like cells getting old and tired and eating a nap.
SPEAKER_00Right, the fatigue theory.
SPEAKER_02Yeah, like they just run out of gas. But it's way more aggressive than that. It's an active state.
SPEAKER_00It is an incredibly active state. It's not passive decay at all. So let's step back and look at the basics of how your body maintains itself. In normal, healthy tissue, your cells divide. They replicate to replace old, damaged, or dead tissue. You get a cut, your skin cells divide to heal it. But, and this was a massive paradigm shift in biology, they cannot do this forever.
SPEAKER_02Wait, really? I thought that was the whole point of cells. They just keep copying themselves.
SPEAKER_00For a long time, scientists thought that too. Back in the early 20th century, there was this famous, though highly flawed experiment by Alexis Carroll, where he claimed to keep chicken heart cells dividing in a lab for decades.
SPEAKER_01Oh, wow.
SPEAKER_00Yeah, people thought cells were essentially immortal. But then in 1961, these researchers, Leonard Hayflick and Paul Moorhead, completely shattered that myth. They discovered that human cells cultured in a lab have a strict hardwired limit on how many times they can divide. It's called the Hayflick limit, usually around 40 to 60 divisions for a human cell.
SPEAKER_02Aaron Powell So they literally just hit a wall, like a biological kill screen in a video game.
SPEAKER_00Aaron Ross Powell Exactly. And the mechanism behind this wall is fascinating. It largely comes down to telomeres.
SPEAKER_02Aaron Powell Oh man. Okay. I know exactly where this is going. Every biology textbook I ever read uses that same awful metaphor for telomeres. The little plastic caps at the end of your shoelaces.
SPEAKER_00Trevor Burrus, Jr. It's everywhere.
SPEAKER_02Trevor Burrus, I always hated that. It never made sense to me. What happens when the cap falls off, the DNA shoelace just frays into strings?
SPEAKER_00Aaron Powell I agree. The shoelace analogy is incredibly overused and honestly functionally misleading. A much better way to think about a telomere is like a prepaid biological debit card for cell division.
SPEAKER_02Trevor Burrus, oh I like that. Okay, so every time the cell divides, it swipes the card.
SPEAKER_00Aaron Ross Powell Exactly. Every time a cell replicates its DNA to divide, the machinery that copies the DNA can't quite reach the very, very end of the strand. So a tiny piece of the telomere, which is just a repeating sequence of junk DNA that doesn't code for anything important, is left off. It's the transaction fee.
SPEAKER_02Right.
SPEAKER_00You swipe the card, you lose a little bit of the balance, the telomere gets physically shorter.
SPEAKER_02Okay, I'm tracking. So you keep dividing, you keep swiping the card, and eventually the balance hits zero, card decline.
SPEAKER_00Card decline. The telomere becomes critically short. And when that happens, the cell's internal sensors freak out. They recognize that if they divide again, they won't be cutting into junk DNA. They'll be cutting into essential crucial genes.
SPEAKER_01Oh, it makes sense.
SPEAKER_00The cell realizes I am severely damaged. If I replicate now with broken DNA, I might mutate. I might become a cancer cell.
SPEAKER_02Ah. So the climate isn't a flaw, it's a safety mechanism. It's slamming the brakes before the car goes off the cliff.
SPEAKER_00Precisely. It's an incredibly elegant tumor suppressor mechanism. And usually when a cell reaches that state or if it experiences severe acute stress like a massive dose of radiation or intense oxidative stress or certain viral infections, it is supposed to do the biologically noble thing. It triggers a programmed self-destruct sequence.
SPEAKER_02Aoptosis.
SPEAKER_00Yes, apoptosis. The cell neatly and quietly packages its internal components into these little lipid vesicles and it sends out a signal to the immune system. Macrophages, which are essentially your body's garbage trucks, swoop in and eat the vesicles.
SPEAKER_02Just cleans it right up.
SPEAKER_00It's clean, it doesn't cause inflammation, and the surrounding tissue is completely unharmed. That is how a healthy body stays young and functional.
SPEAKER_02But and I'm guessing this is the crux of the whole deep dive. Sometimes they don't do the noble thing.
SPEAKER_00Sometimes they absolutely refuse to die.
SPEAKER_02They just say no. They override the self-destruct.
SPEAKER_00They override it completely. They arrest their cell cycle, meaning they permanently, irreversibly stop dividing, but they stay alive, they dig in, they turn on these highly specific, highly robust anti-apoptotic pathways. Basically, they raise internal blast shields to resist their own death signals.
SPEAKER_02Dude, that is deeply creepy.
SPEAKER_00And that that is what a senescent cell is. That is your zombie. It's not dead, it refuses to die, but it is entirely stripped of its normal, healthy function.
SPEAKER_02It just sits there taking up space, refusing to clock out. But wait, if they're just sitting there, not dividing, why are they such a massive problem? Like if I have a zombie cell parked in my bicep or my liver and it's not turning into cancer, who cares? Why is it driving systemic aging?
SASP Toxic Sludge Spreads Damage
SPEAKER_00Aaron Powell Because they aren't just sitting there quietly taking up space. This is the biggest misconception about senescence. They are highly, frantically metabolically active and they are screaming. Screaming. Chemically screaming. And this introduces a piece of jargon that is absolutely central to everything we're talking about today. It's an acronym, S-A-S P. It stands for the Senescence Associated Secretary Phenotype.
SPEAKER_02S-A-S-P. Honestly, looking at the papers, phenotype feels way too clinical. I'm just going to call it Toxic Zombie Sludge because when you read what it actually does to the surrounding tissue, it sounds like radioactive sludge.
SPEAKER_00You know, toxic zombie sludge is scientifically crude, but it is functionally brilliant because it really captures the destructive nature of it. But to give you the precise biological breakdown, this sludge is a highly complex, continuously secreted cocktail of proteins.
SPEAKER_02Okay, what kind of proteins?
SPEAKER_00We are talking about pro-inflammatory cytokines, specifically things like interleukin-6 or IL6 and interleukin 8. We're talking about chemokines, which summon immune cells to the area. We're talking about heavy-duty growth factors. And worst of all, proteas.
SPEAKER_02Wait, remind me what a protease does. It breaks things down, right?
SPEAKER_00Yes. Proteases are enzymes that literally chew up proteins. Matrix metal proteinases specifically degrade the extracellular matrix, the structural scaffolding that holds your tissues together.
SPEAKER_02So they're actively destroying the neighborhood.
SPEAKER_00They are.
SPEAKER_02It's like a bad tenant. They park on the lawn, they refuse to leave, and then they just start dumping battery acid on the grass, throwing trash everywhere, and blasting loud music all night to keep everyone else awake.
SPEAKER_00That is a phenomenal analogy. The tissue degradation is very real, but it gets even worse than the battery acid on the lawn. Because of the specific nature of this SCSP sludge, it doesn't just degrade the scaffolding. It actually infects the neighboring healthy cells. Researchers call it the bystander effect.
SPEAKER_02Hold on. You're saying the sludge from the zombie hits a perfectly healthy cell next door and does what? Does the healthy cell die?
SPEAKER_00No, it doesn't die. The inflammatory signals, especially the cytokines and the reactive oxygen species in the SSP, cause immense stress to the healthy neighbor. And that stress forces the healthy cell to also trigger its blast shields, lock its cell cycle, and become senescent.
SPEAKER_02No way. It actually turns them into zombies too.
SPEAKER_00It does.
SPEAKER_02It's a literal zombie bite. One gets infected, turns, and then immediately starts biting the neighbors. That is insane. It's an exponential infection model.
SPEAKER_00It is exactly an infection model, just driven by chemistry rather than a virus. And as this chain reaction spreads through a tissue, it drives a massive systemic problem that researchers have termed inflammaging.
SPEAKER_02Inflammaging. Inflammation plus aging.
SPEAKER_00Exactly. It's this chronic, low-grade, simmering systemic inflammation that creeps up on all of us as we get into our 40s, 50s, and beyond. If you look at the sources, the medical consensus is crystal clear. This inflammaging, driven at its core by the SAP sludge, is fundamentally linked to almost every major disease of aging.
SPEAKER_02Like what specifically?
SPEAKER_00Cardiovascular disease, atherosclerosis, type 2 diabetes, neurodegeneration like Alzheimer's and Parkinson's, osteoarthritis, and ironically late-life cancers.
SPEAKER_02Wait, ironically, because you just said senescence evolved to stop cancer.
SPEAKER_00But it does initially. But remember that SASP cocktail. It's full of growth factors and enzymes that chew up the tissue matrix. If a legitimate cancer cell does manage to form nearby, that degraded tissue and those growth factors provide the perfect fertile soil for a tumor to rapidly grow and metastasize. It's a tragic paradox.
SPEAKER_02Okay, I have to push back here. Because my brain is spinning.
SPEAKER_00Go for it.
Why Evolution Keeps Zombie Cells
SPEAKER_02If these zombie cells are so incredibly toxic, if they literally secrete a sludge that melts our tissues, infects other cells, and causes our bodies to break down and die, why did evolution let them exist? Why didn't our bodies just evolve to instantly nuke any cell that turns senescent? It seems like a massive glaring design flaw in the human blueprint.
SPEAKER_00That is the million-dollar question in gerontology. And the answer lies in a concept called antagonistic pleiotropy.
SPEAKER_01Okay, that is a mouthful. Unpack antagonistic pleiotropy for me.
SPEAKER_00It sounds intimidating, but the concept is simple. It refers to a biological feature or a gene that is highly beneficial when you are young and trying to survive, but becomes actively detrimental when you are old. You have to remember how evolution works. Right. Evolution only really cares about one thing: getting you to reproductive age and keeping you alive long enough to raise your offspring. What happens to your joints or your brain at age 70 or 80, evolution doesn't care. There's no evolutionary pressure to fix problems that only kill you after you've passed on your genes.
SPEAKER_02So you're saying the zombie sludge, the SAP, is actually good for you when you're young?
SPEAKER_00It is absolutely crucial for your survival. Here's the twist that blows people's minds. When you're young, say you're a healthy 20-year-old and you get a severe cut or a muscle injury, cells in that specific area temporarily become senescent. They rapidly pump out that SAP sludge. But in a young, healthy body, that acute burst of inflammation isn't a chronic burn. It's a massive glaring signal flare.
SPEAKER_02Like calling 911.
SPEAKER_00Exactly. Tells your immune system, hey, massive damage here. Send the macrophages, send the repair stem cells immediately. The SAP actually orchestrates the wound healing process. It promotes tissue regeneration. Oh wow. And even crazier, during embryonic development, when you are literally a fetus growing in the womb, transient senescent cells use their SAP to help sculpt the growing tissues. They create the temporary scaffolding, signal the growth, and then gracefully clear out.
SPEAKER_02Wait, wait, wait. We use zombie sludge to grow as embryos, that's how we develop.
SPEAKER_00We do. Without senescence, you wouldn't develop properly. The mechanism is a masterpiece of biology. The problem isn't that senescent cells exist. The system works perfectly when we are young. The cell gets damaged, turns senescent, shoots up this view flare, stops itself from becoming cancer, and then the immune system, the garbage trucks, sees the flare, swoops in, and eats the senescent cell. Tissue healed, danger averted.
Immune Aging Lets Zombies Accumulate
SPEAKER_02Okay, so the system is a closed loop. What breaks? Why do they accumulate when we're older?
SPEAKER_00What breaks is the immune system itself. As we age, our immune system undergoes a parallel process called immunosinescence. The garbage trucks get tired, the macrophages become less efficient at recognizing the SAC flares, the natural killer cells get sluggish.
SPEAKER_02Oh, so the dispatcher is ignoring the 911 calls.
SPEAKER_00Precisely. The senescent cells are still forming because your cells are still dividing, getting stressed by toxins, poor diet, UV radiation, simple time, and they are still shooting at their SAC flares. But the immune system just stops showing up to clear them out.
SPEAKER_02So they just sit there, multiplying.
SPEAKER_00They accumulate. And because of that bystander effect we talked about, the longer they sit there, the more healthy neighbors they infect. The inflammation transitions from being a helpful, acute alarm bell into a chronic, low-level, relentless burn. And that chronic burn is what slowly destroys your tissue architecture over decades.
Senolytics And The Cell Kill Switch
SPEAKER_02Wow. Okay. That makes perfect sense. It's a failure of clearance, not a failure of design. So the immune system is slacking off, the zombies are biting the neighbors, the tissue is filling up with sludge, which perfectly leads us into the logical next step. If our bodies can't naturally clear them out anymore, how do we intervene? How do we build an artificial garbage truck to flush them out?
SPEAKER_00And this brings us to the advent of senolytics. The drugs designed to do exactly what our immune system forgot how to do.
SPEAKER_02Right. Let's talk about killing them. Because if you want to kill a zombie, you have to know how it's surviving. You mentioned earlier they have blast shields.
SPEAKER_00Yes. To understand a senalytic drug, you have to understand the S keeps senescent cell anti-apoptotic pathway.
SPEAKER_01The blast shields.
SPEAKER_00Exactly. When researchers first started trying to kill these cells, they realized it was incredibly difficult. The cells were stubborn. So they did these massive biointraumatic screens. They looked at the transcriptum, meaning they looked at exactly which genes were turned on and which were turned off in a senescent cell compared to a healthy cell. Right. And they found that senescent cells heavily, desperately rely on certain survival networks, specifically families of proteins like the BCL2 family or certain tyrosine kinases.
SPEAKER_02Okay, break those down for me. What is a tyrosine kinase doing in this context?
SPEAKER_00Think of a tyrosine kinase, like a highly specific switchboard operator inside the cell. Its job is to take signals, often survival signals, and pass them down the chain to tell the cell, keep the blast shields up, do not trigger apoptosis, stay alive. Senescent cells have these switchboards jammed in the on position. They are completely dependent on these specific pathways to survive the massive internal stress of being a zombie.
SPEAKER_02So they're basically on life support.
SPEAKER_00Exactly. They are teetering on the edge of self-destruction, only kept alive by these hyperactive SDFC shields. So the theory was born. What if we use a drug to just temporarily jam the switchboard? Turn the shield off for just a minute. A healthy cell wouldn't care because a healthy cell isn't under massive stress, it doesn't need emergency shields to survive.
SPEAKER_02But a senescent cell-If you pull the plug on its life support, even for a second, the whole thing crashes and it dies?
SPEAKER_00Yes, it's pushed over the edge into apoptosis, it finally dies. Drugs that do this are called senolytics. They selectively induce death in senescent cells while leaving healthy cells entirely alone. And the fascinating thing is, when researchers figured this out, they didn't have to invent a completely new drug from scratch. The very first wave of synolytics were compounds we already had in the pharmacy in the grocery store.
SPEAKER_02Yes. Okay, let's talk about the most famous combo in this space, because this is where the human data gets wild. D plus Q.
SPEAKER_00Dacidamib and Quircetin.
SPEAKER_02Right. So D is docetamib, which, if I'm reading this right, is an intense FDA-approved leukemia drug. It's literal chemotherapy. And Q is quercetin, which is a natural flavonoid plant compound. You can buy it in a plastic bottle at the vitamin Ile. It's in apples, onions, capers. How did they end up pairing a heavy-duty cancer drug with an apple extract?
SPEAKER_00It comes back to those switchboards. Docitative is a broad spectrum tyrosine kinase inhibitor. It's very good at jamming certain survival signals, specifically the efferin-dependent pathways, but it doesn't hit all of them. Quircetin, on the other hand, inhibits completely different survival pathways like PI3K and certain serpents. Neither one of them is strong enough to clear out all types of senescent cells on their own.
SPEAKER_02But together cover each other's blind spots.
SPEAKER_00Precisely. Together, they hit multiple SCOA shields simultaneously across different tissue types. It was the ultimate one-two punch. And the preclinical data in mice was absurd. It extended their lifespan, rejuvenated their cardiovascular systems, but mice are mice. The real question was what happens in a human?
Dasatinib Plus Quercetin Human Results
SPEAKER_02Which brings us to the Republic of Georgia trial. This was a 2019 clinical trial, and reading the methodology of this study honestly blew my mind. So they took 64 men, middle aged to older, the average age was around 53, and they gave them this D plus Q combo. But here is the part that I found so crazy the dosing schedule. They didn't put them on a daily pill. They gave them 50 milligrams of decetinib and 500 milligrams of quercetin once a day for just five days, and then they stopped completely.
SPEAKER_00This is a crucial concept in senotherapeutics. It's called a hit and run dosing strategy. Think about the biology. Senescent cells do not divide, they can't multiply. So if you go in with a senolytic strike team and clear out, say 30% of the zombies over five days those cells are gone, it'll take weeks, maybe months, for the natural stresses of life to accumulate a new batch of senescent cells.
SPEAKER_02So you don't need to suppress the pathway constantly.
SPEAKER_00Exactly. And that is incredibly fortunate because as you mentioned, dustatinib is a chemotherapy drug. If you take it every day for months, it has massive side effects, immunosuppression, bleeding, severe fatigue. But a five-day pulse, the side effects are minimal.
SPEAKER_02Okay, so five days of pills, then they waited 21 days, three full weeks. The drugs are completely metabolized, long gone from their bloodstream, and then they tested them. They had these guys do a stair ascending test. And this isn't just can you walk upstairs? They are hooking them up to blood pressure monitors, timing their endurance, seeing how their cardiovascular system handles the acute stress of climbing four flights, and the results The results were a profound proof of concept. Weeks after the drugs were gone, these 53-year-old men had significantly improved physical endurance. Their times were faster. But the craziest part was the blood pressure. Their systolic blood pressure dropped, and their vitals stabilized way faster after the exercise. I need you to explain the how here. How does clearing out some random zombie cells three weeks ago suddenly make a guy's blood vessels work better today?
SPEAKER_00It's all mechanical, driven by the removal of the SASP. Remember when we talked about the proteases and the toxic sludge, the enzymes that chew up the extracellular matrix?
SPEAKER_02Yeah, the ones destroying the neighborhood scaffolding.
SPEAKER_00Right. Your blood vessels rely on a protein called elastin to remain stretchy and flexible. That flexibility is what regulates your blood pressure. When your cardiovascular system is loaded with senescent cells, the constant bath of SAP proteases literally chews up that elastin. The blood vessels become stiff. Stiff vessels mean high blood pressure.
SPEAKER_01Oh that is crazy.
SPEAKER_00When the D plus Q pulsed through their system, it triggered apoptosis and a fraction of those senescent cells in the endothelial lining of the vessels. The cells died, the macrophages cleared the debris, and suddenly the SSA sludge vanished. The proteases stopped chewing up the elastin. The vessels rapidly regained their natural elasticity, which mechanically lowered the blood pressure. And on top of that, without the systemic inflammation, practically everyone in the active D plus Q group reported feeling a literal lightness in the joints the very next day.
SPEAKER_02Dude, that is unbelievable. So it's not a stimulant, it's not masting a symptom, it's structurally repairing the tissue by removing the toxic variable. If I'm a listener right now, my immediate thought is: okay, where do I get a prescription for DAS at nib? I want my joints to feel light tomorrow.
Who Benefits And Who Risks Harm
SPEAKER_00And that is exactly where I need to step in and throw a massive bucket of cold water on the hype. Because while the Georgian trial is incredibly exciting, science is never just one study. One study is an anomaly, multiple studies are data. We have to look at the Mayo Clinic trial that was also in our sources because this adds some very dry, very necessary clinical reality to the conversation.
SPEAKER_02All right, hit me with the reality check.
SPEAKER_00The Mayo Clinic conducted a phase two, randomized placebo controlled trial using the exact same D plus Q. Combination, the same protocol. But this time they tested it on 60 healthy postmenopausal women.
SPEAKER_02Why specifically postmenopausal?
SPEAKER_00Because of estrogen. When women go through menopause, estrogen levels plummet. Estrogen is heavily involved in regulating bone metabolism. Without it, bone resorption, the breaking down of bone, accelerates, which is why osteoporosis is such a massive risk. And cellular senescence in the bone marrow is a huge driver of this. The senescent cells secrete SESP that hyperactivates osteoclasts, the cells that eat bone. So the Mayo Clinic wanted to see if we give these women D plus Q, can we kill the senescent cells and improve their bone formation markers?
SPEAKER_02Okay, that makes total sense. So they tracked their bone markers. What happened? Did it work?
SPEAKER_00Well, yes and no. It did have a beneficial effect on bone formation markers like P1MP, it reduced bone resorption, it did biologically what it was supposed to do. But, and this is a massive, highly critical, but when they dug into the data, they found it only benefited the women who already had a significantly high baseline burden of senescent cells.
SPEAKER_02Wait, really? Only the ones with a high burden.
SPEAKER_00Yes. They measured the senescence burden before the trial started. If a woman had a relatively low number of senescent cells to begin with, if her biological age was doing okay, the D plus Q did virtually nothing for her bone health. The markers barely moved.
SPEAKER_02Oh, so it's not a prophylactic. It's not a magic anti-aging vitamin that just buffs your stats.
SPEAKER_00Not at all. Dr. Sundit Kosla, who is a brilliant researcher and the senior author from the Mayo Clinic on this, gave a very stark warning about this exact dynamic. He pointed out that there are tens of thousands of people out there right now reading the headlines, buying commercial coracetin online, and taking it every single day as an anti-aging supplement. But his point is foundational. If you don't actually have a high burden of senescent cells in your tissues, taking a senolytic won't do anything for you.
SPEAKER_02It's like taking a highly potent weed killer, walking out to a perfectly manicured lawn that doesn't have a single dandelion on it, and just spraying chemicals everywhere. You're not making the grass healthier, you're just pouring poison on a healthy lawn for no reason.
SPEAKER_00That is the perfect analogy. If there are no zombies to kill, the zombie-killing drug does not make you younger. And it's not just useless, it carries risk. Taking high doses of kinase inhibitors, even natural ones when you don't need them, is just asking for off-target side effects. You're jamming cellular switchboards that might actually need to be on.
SPEAKER_02Right, because healthy cells need those pathways too.
Fisetin Fails In Real Humans
SPEAKER_00Exactly. Koslan noted that people with accelerated aging conditions, like cancer survivors who went through heavy chemotherapy, chemo massively induces cellular senescence, which is why chemo survivors often suffer from early frailty and heart issues. Or people with severe obesity or progeroid syndromes, those people have massive zombie burdens. They might benefit immensely from D plus Q. But a relatively healthy 40-year-old taking kerosetin every morning hoping to live to 120, you're probably just making incredibly expensive urine.
SPEAKER_02Okay, if you're listening to this and looking at that bottle of supplements on your kitchen counter, you might be feeling a little betrayed right now, which makes this the perfect time to talk about the absolute king of the supplement hype cycle right now, physicin.
SPEAKER_00Yes. We absolutely have to talk about physiotin.
SPEAKER_02Because if you go online to any biohacking forum or listen to certain optimization gurus, physicin is the golden child. It's another natural flavonoid, very similar to quercetin. You find it naturally in strawberries, apples, persimmons. And the hype didn't come out of nowhere. In petri dishes, in vitrofeasitin looked like an absolute miracle. It looked like a highly potent synolytic, maybe even better and safer than the D plus Q combo, and you don't need an oncologist to prescribe it to you, so people are buying it in bulk. But our stack of sources includes a very recent, highly rigorous clinical trial from the Stedman Philippon Research Institute in Colorado, and this trial is a total wake-up call.
SPEAKER_00It really is. This was a phase one and two randomized, double-blind, placebo-controlled trial. That is the absolute gold standard of clinical research. No bias, no guessing.
SPEAKER_02Exactly. Let's break down the setup. They took 74 subjects, ranging from 40 to 80 years old, who all had radiographically confirmed osteoarthritis in their knees. We are talking severe, bone-on-bone, painful joint degradation. And the biological rationale here is rock solid. We know from extensive literature that osteoarthritic joints are basically ground zero for senescence. The cartilage is absolutely packed with senescent chondrocytes, and the SSP inflammation is what drives the pain and the cartilage is destruction.
SPEAKER_00So the setup is pristine. You have a localized, highly burdened target area.
SPEAKER_02Right. So they split the group, half get a placebo, half get oral physicin. And the dosing protocol was intense. They gave them 20 milligrams per kilogram of body weight. So for an average guy, that's like taking a massive fistful of capsules. They did it for two consecutive days, then 28 days off. The hit and run strategy again, they did three full cycles of this, and then they tracked these patients for an entire year. And they didn't just ask, how do your knees feel? They did deep metric tracking. They used MRI T2 mapping.
SPEAKER_00Which, for context, is an advanced imaging technique that allows you to see the microscopic water content and collagen integrity inside the cartilage. It shows you the actual structural health of the tissue, not just the gross bone gap.
SPEAKER_02Thank you. Yes. They did T2 mapping, they did the WLMAC pain and stiffness surveys, they did 40-meter fast walk tests, timed up and go tests. They measured literally every functional metric you can think of.
SPEAKER_00Aaron Powell And what did the year of data reveal?
SPEAKER_02Total, absolute failure.
SPEAKER_00Aaron Powell Completely null results across the board.
SPEAKER_02Aaron Powell I was reading the graphs and the source data, and it's almost comical in a dark way. The trend lines for the Fissetin group and the placebo group are practically glued together. No significant differences in the MRI cartilage scans. The cartilage kept degrading at the same rate. No difference in pain reduction. No difference in physical function, knee strength, or gate speed. Honestly, reading it made me a bit angry. Because people are dropping real cash on this stuff, they are popping these massive doses of pills, and it's doing literally nothing in a human body.
SPEAKER_00It is deeply frustrating, but it is a harsh, necessary lesson in translational medicine. And the lesson is this. Just because a molecule successfully assassinates a zombie cell in a perfectly controlled artificial water-based environment like a petri dish, does not mean that swallowing a plastic capsule of it will fix your biological hardware.
SPEAKER_02Okay, so unpack the why here. If fecetin is a proven sanolytic in the lab, why did it fail so spectacularly in the humans? Did they not use a high enough dose?
SPEAKER_00It's not a dosage issue. It fundamentally comes down to pharmacokinetics, specifically a concept called bioavailability. Ficetin, in its pure, natural molecular form, is highly, highly hydrophobic. It actively repels water.
SPEAKER_02Like trying to mix olive oil into a glass of tap water, it just clumps up and separates.
SPEAKER_00Exactly. Now think about your digestive system. Your stomach acid, the mucosal lining of your intestines, your bloodstream, your body, is overwhelmingly water. When you swallow pureficitin powder, it hits that watery environment and struggles to dissolve. And even if a little bit gets absorbed to the gut lining, it immediately hits the liver. The liver's entire job is to filter out foreign, poorly soluble compounds. It undergoes what's called massive first-pass metabolism. The liver shreds the cissetin and excretes it before it ever gets a chance to circulate in the blood, let alone penetrate the dense vascular tissue of the synovial fluid inside a knee joint.
SPEAKER_02So the physicin wasn't failing to kill the zombie cells, it just never even reached the battlefield. It was intercepted at the border.
SPEAKER_00That is the most medically probable explanation. Swallowing pure fysitin is like trying to wash your car with a sponge wrapped in duct tape. The soap is in there, but it can't get out to do the work. And this highlights a massive, foundational lesson for anyone interested in longevity science. Delivery mechanisms matter just as much, if not more, than the drug itself. You could have the greatest, most lethal biochemical warhead in the world, but if you do not have a missile guidance system that can successfully deliver it to the target tissue, the warhead is completely useless.
SPEAKER_02Man, that is a brutal reality check. And the researchers in the study were pretty clear about this, right? They didn't say the concept of synolytics is dead. They just said this specific oral formulation of physicin is a dead end.
SPEAKER_00Correct. They are currently looking into liposomal physicin, or injecting it directly into the joint. But the oral supplement you buy online, the data says it's functionally inert for your knees.
Senomorphics That Muzzle The SASP
SPEAKER_02Wow. Okay, so let's summarize the pill strategy. D plus Q works, but maybe only if you're already carrying a massive toxic burden of senescent cells. Physicin is a highly potent weapon that essentially detonates in your liver before it reaches the target. This whole nuke them from orbit with pill strategy is proving to be highly complicated, messy, and riddled with collateral damage issues. Which is why some scientists are stepping back and saying, hey, if killing these cells is this incredibly difficult and risks harming the tissue, maybe we shouldn't be trying to kill them at all.
SPEAKER_00It's a completely different paradigm shift.
SPEAKER_02Right. What if, instead of dropping a bomb on the zombie, we just sneak up, tape its mouth shut, and walk away, let it live, but stop it from spitting out the toxic sludge.
SPEAKER_00Welcome to the fascinating world of xenomorphics.
SPEAKER_02Okay, I love this concept. Let's break down xenomorphics. If I'm trying to conceptualize this, how does the biological mechanism differ from what DOCTANIB does?
SPEAKER_00It's a fundamental difference in the ultimate goal. A senolytic like Dacetanib is a biochemical assassin. Its entire singular job is to jam the survival switchboard, trigger apoptosis, and eradicate the physical cell entirely. It leaves a microcrater where the cell used to be. A xenomorphic, on the other hand, is a modulator, a diplomat almost. It does not kill the cell. Instead, it enters the senescent cell and specifically targets the transcription pathways that manufacture the SEP sludge.
SPEAKER_02Like shutting down the factory assembly line.
SPEAKER_00Exactly. It blocks the internal signals, often pathways like NF kappa B or MTOR that tell the cell to produce interleukin 6 and all those destructive proteases. The cell stays alive. It remains in its state of arrested division. But it is completely silenced.
SPEAKER_01Muzzled.
SPEAKER_00Muzzled. You halt the bystander effect, you radically drop the local tissue inflammation, but the physical bulk of the cell remains perfectly intact.
SPEAKER_02Okay, I have a source here that perfectly illustrates this in the real world. It's about a proprietary peptide called OSR1. It was developed by a longevity skincare company called OneSkin. And their data is super interesting because they aren't testing this on mice. They applied this OSR01 peptide to actual human skin samples, like literal ex vivo skin tissue grown in a lab. And they measured the S Azo markers before and after.
SPEAKER_00And what do the transcription markers show?
SPEAKER_02The OSO1 significantly reduced the levels of interlichin 6 and CXCO1, which we know are the major inflammatory alarm bells in the SASP. But here is the key it did this without reducing the overall cell viability count. It didn't kill a single cell. Because of that, the researchers officially classified OSO1 as a cinomorphic, and the physical results were wild. By just turning off the toxic sludge, they saw reduced melanin deposits, meaning less hyperpigmentation, fewer age spots, and they actually saw an increase in epidermal thickness. The skin structurally started acting younger, thicker, more resilient, purely because the chemical alarm bells were finally turned off.
SPEAKER_00It is a highly elegant, highly effective approach, especially for dermatology.
SPEAKER_02But I have to ask, and I feel like anyone listening is thinking the exact same thing. Honestly, why wouldn't we just want to nuke them? I get that muzzling them works for a cosmetic skin cream, but internally, it feels like finding a live bomb in your living room, pulling the firing wires out, and then just leaving the casing sitting on your coffee table forever. Why leave a muzzled zombie taking up space in your body? Shouldn't we just sweep them into the trash and let new cells grow?
SPEAKER_00That is a highly intuitive question, and it's the exact debate happening in gerontology right now. But the nuke them all approach ignores the sheer physical reality of human tissue architecture. I want you to think about what happens if you have an organ that is heavily, heavily burdened with senescent cells. Let's say you are 75 years old, and 15% of the cells in a critical area of your skin, or worse, a critical area of your brain, are senescent.
SPEAKER_02Okay. 15% is a lot.
SPEAKER_00It's a massive amount. Now, if you come in with a highly potent, perfectly absorbed synolytic and you successfully nuke all of them, you have just suddenly violently eradicated 15% of the physical mass of that tissue. Yeah.
SPEAKER_02Oh wow. You're leaving holes.
SPEAKER_00You're leaving microscopic, cavernous holes everywhere. Now, in some tissues, this is fine. In your liver or your blood, the surrounding healthy stem cells can rapidly divide, fill the gaps, and the tissue regenerates like nothing happened. But what about tissues that do not regenerate easily? Or at all?
SPEAKER_01Like the brain.
SPEAKER_00Exactly. Neurons in the central nervous system are largely postmitotic. They do not divide to replace themselves. If you aggressively kill off senescent neurons or the senescent glial cells that physically support the neurons, your body might not be able to replace them. You can induce rapid catastrophic structural degradation. You could literally accelerate dementia by trying to cure it.
SPEAKER_01Wow, that's terrifying.
SPEAKER_00Right. Or take the skin. If you kill off 15% of the dermal fibroblasts all at once, the skin might just physically collapse, losing all its structural integrity and wrinkling dramatically. In those highly specific sensitive environments, you absolutely do not want to reduce the overall cell count. You need a physical bulk of the cell to maintain the 3D scaffolding of the tissue.
SPEAKER_02Dude, so the zombie is still holding up the wall.
SPEAKER_00Yes. It's a load-bearing zombie. You just need it to stop screaming and setting the room on fire with its SASP.
SPEAKER_01Yeah.
SPEAKER_00That is why xenomorphics are incredibly important. Sometimes muzzling the zombie is the much safer, much more viable biological option than total eradication.
SPEAKER_02A load-bearing zombie. That is brilliant. It makes total sense. You can't just knock down the pillars of a building because they're ugly. Okay, so we use xenomorphics for delicate, non-regenerating tissues. But what about the organs where we do want to wipe the board clean, like the kidneys or the liver, where we really do want to completely eradicate the zombies, but we don't want to rely on these poorly absorbed plant powders, and we don't want the collateral damage of broad spectrum chemo drugs.
SPEAKER_00Right. If you want to clear them out safely, you need to abandon the small molecule pills entirely.
SPEAKER_02Exactly. Which means we are moving past the pharmacy and into pure sci-fi territory. We need precision. We are moving from dropping dumb bombs to sending in precision-guided munitions. Let's look at oisin biotechnologies. This is a biotech startup, and their approach is so radically different from DOCTINIB or physitin. They aren't using chemicals to poison the cells. They are using suicide gene therapy delivered via a proteolipid vehicle.
SPEAKER_00Okay, you're the expert here. Explain the physics of a proteolipid vehicle. How does that actually work in the bloodstream? It's brilliant engineering. Think of a proteolipid vehicle as a microscopic, highly stealthy Trojan horse. It is essentially a tiny synthetic nanoparticle bubble made out of fats, lipids, and specific targeting proteins. Inside this hollow bubble, they hide a piece of engineered DNA. This bubble is injected into your bloodstream. And because its outer shell is made of the exact same lipid material that your cell membranes are made of, when it bumps into a cell, it doesn't bounce off. It seamlessly fuses with the cell membrane, melting into it, and safely drops its DNA payload directly inside the cell.
SPEAKER_02Okay, so the Trojan horse gets inside the city walls, it drops the synthetic DNA into the cell. What does the DNA actually do? Does it just start making poison?
SPEAKER_00This is the genius part, and it solves the collateral damage problem completely. The DNA they drop inside is programmed to be completely inert. It's a dormant script. It does absolutely nothing unless it finds itself inside a cell that is actively expressing senescence markers.
SPEAKER_02Wait, how does it know?
SPEAKER_00Because of the promoter sequence, they engineer the DNA to only activate if it detects a specific cellular environment. Usually they target the P16 promoter. The P16 gene is massively hyperactive in senescent cells. It's one of the main pathways they use to lock their cell cycle. If the Trojan horse drops the DNA into a healthy normal cell, the healthy cell's internal machinery looks at the DNA, doesn't recognize the P16 trigger, and just ignores it. The DNA harmlessly degrades. Nothing happens.
SPEAKER_02But if it drops into a zombie cell.
SPEAKER_00If it drops into a zombie cell, the cell's own road, hyperactive P16 machinery accidentally reads the DNA sequence. It triggers the script. And the script contains the explicit overriding instructions for the cell to commit suicide. It forces the cell to activate Caspace 9, which triggers apoptosis from the inside out.
SPEAKER_02That is ruthless. It literally uses the zombie's own corrupted machinery against it to pull the trigger.
SPEAKER_00Highly targeted, highly specific. It completely bypasses all of those SCP blast fields we talked about because it's not trying to batter the cell from the outside with kinase inhibitors. It's stealthily rewriting the software from the inside to command a self-destruct.
SPEAKER_02Aaron Powell And their primary target right now is chronic kidney disease, CKD, right?
SPEAKER_00Yes. The kidneys are highly, highly susceptible to senescent cell accumulation as we age. And as those cells build up, the SESP sludge drives intense fibrosis, which is essentially internal scarring. It scars the delicate filtration systems of the kidney until they fail. Currently in modern medicine, there is very little we can do to reverse CKD. You just manage the decline until you need dialysis.
SPEAKER_02But Oisin tested this in mice.
SPEAKER_00They did. And the preclinical data in mice is staggering. By repeatedly clearing out the senescent cells using this precision gene therapy, they significantly reduced the senescent burden in the kidneys. They physically halted the fibrosis, the kidneys started functioning better. And most incredibly, when they gave this to naturally aged mice, just regular old mice, not genetically modified ones, this technology extended their median healthy lifespan by over 20 percent.
SPEAKER_02If you extrapolate that to a human lifespan, that's like adding 15 or 20 healthy, vibrant years to someone's life. Not just frail years, but functional years.
SPEAKER_00It is an astonishing number. Now we always have to caution that mice are not humans. We've cured cancer in mice a thousand times. But the precision of the delivery mechanism, the fact that it avoids the liver toxicity of physicin and the broad spectrum damage of docetinib is what gives researchers so much legitimate hope.
SPEAKER_02And oison isn't the only team looking at precision targeting. There is a massive crossover happening right now from the oncology world. Let's talk about CAR T cell therapy, because anyone who follows cancer research knows CAR T. It is the ultimate personalized medicine. You take a patient's own white blood cells out of their body, you take them to a lab, you biologically reprogram them to recognize a specific cancer marker, and you multiply them. You basically train a million of your own immune cells to act like special forces, and then you put them back in the body to hunt the cancer.
SPEAKER_00That's a perfect summary of CAR T. It absolutely revolutionized the treatment of liquid tumors like leukemia and lymphoma. And now researchers have had a massive realization. If we can train the immune system to hunt cancer cells, why can't we use that exact same special force as training to hunt senescence cells?
SPEAKER_02Right, because the whole problem is immunosinescence. The immune system forgot how to find the zombies, so we just retrain them. But wait, how do the immune cells know which one is the zombie? You can't target P16 because that's on the inside of the cell. T cells only see the outside.
SPEAKER_00Exactly. They need a surface target, a beacon. And researchers at places like Cold Spring Harbor Laboratory discovered a unique, highly specific cell surface receptor called UPR, urokinase plasminogen activator receptor. It's a mouthful, but what matters is that UPR is broadly heavily expressed on the outer membrane of senescent cells, but it is almost entirely absent on healthy cells.
SPEAKER_02So it's literally like a glowing neon sign on the zombie's forehead.
SPEAKER_00Exactly, a neon sign that says I am senescent. So scientists engineered CAR T cells to exclusively hunt down anything wearing that UPIA sign. They took these UPR-directed CAR T cells and infused them into mice.
SPEAKER_02And let me guess, it worked.
SPEAKER_00The immune cells acted like a highly trained HIT squad. They rapidly and efficiently eradicated the senescent cells across multiple tissues. They reversed liver fibrosis induced by chemicals. And incredibly, they even extended survival in mice that had lung cancer. Not because the T cells attacked the cancer directly, but because they cleared out the senescent cells and the surrounding tissue that were creating that toxic, tumor-permissive SP environment. They cleaned up the neighborhood and the cancer lost its foothold.
SPEAKER_02Wow. So if we step back and look at the whole evolution of this field, it's incredible. D plus Q was like dropping a wide area bomb. It gets the job done, but you might cause some collateral damage to your cellular switchboards if you don't have enough zombies to justify it. The seating was essentially a dead missile. The warhead was good, but it burned up in the atmosphere of the liver before it ever reached the target. But these genetic Trojan horses and cardiotherapies, that is like sending in a microscopic Navy SEAL team. Total precision, zeroing in exactly on the target, leaving the healthy civilian cells completely untouched.
SPEAKER_00That is exactly the trajectory the longevity field is taking right now, moving rapidly from repurposed blunt chemical instruments to bespoke, hyper-precise molecular machinery.
SPEAKER_02Okay, we have covered a massive amount of ground today. If you are listening to this, digesting all this biology, here's the core summary of what you need to take away. Cellular senescence is real. These zombie cells and the toxic SASP sludge they pump out are a major fundamental mechanical driver of why our bodies age and why we get sick. The therapies to combat the xenolytics, to assassinate them, the xenomorphics, to muzzle the load bearing ones are incredibly real and showing jaw dropping promise in the lab. But, and this is the most important takeaway, we are currently In the messy dial up internet phase of this science.
SPEAKER_00That is such an excellent way to conceptualize it. Dial up internet.
SPEAKER_02Right. Like you hear the screeching modem, it connects, it technically works, but it drops the call half the time. It's slow and it's clunky. Avoid the hype of the over-the-counter quick fixes. Swallowing handfuls of poorly absorbed plant extracts is likely not doing what the Instagram biohacker ads tell you it's doing. You have to be patient. You have to wait for the precision medicine. The Navy SEAL teams are coming, but they are still in basic training in the phase one clinical trials.
Psychoage And The Meaning Of Time
SPEAKER_00Exactly. Protect your health through the boring proven methods, sleep, exercise, diet, while you wait for the biotechnology to mature. But while we wait for those clinical trials to finish, I want to leave you, the listener, with something much deeper to think about. Because we spent this entire hour talking about the raw biology of extending health span, the proteins in the cells, but we haven't talked about the psychology.
SPEAKER_02Oh, I like where this is going. Biology versus psychology.
SPEAKER_00In our stack of sources, buried beneath all the clinical trial data, there is a fascinating report from the Nuffield Council on Bioethics. It explores the profound ethical and psychological considerations of the future of aging, and they introduce this brilliant concept called psychoage. It refers to our subjective psychological age, how old we feel in our minds, and how that feeling dictates our behavior.
SPEAKER_02Right, because an 80-year-old thinks very differently about their future than a 20-year-old does.
SPEAKER_00Exactly. Now I want you to imagine a scenario five, maybe ten years from now. Let's say Oisens Gene Therapy or the Cari T therapies actually cross the finish line. They get FDA approval. They work in humans safely. And suddenly we can reliably medically extend human health span by 20%. You take a targeted treatment at age 60, and suddenly your joints stop aching, your brain fog completely clears, your cardiovascular system operates with the elasticity it had when you were 40, your biological clock effectively stops ticking so loudly in your ear.
SPEAKER_02I mean, that sounds like the ultimate dream. Sign me up.
SPEAKER_00It does sound like a dream. But what actually happens to human psychology when that biological clock stops? Think about it. So much of human ambition, our intense drive to create, to build companies, to paint masterpieces, to start families, to achieve our goals, it is subconsciously heavily driven by the ticking of that clock. We know deeply that our time is limited. Our bodies remind us every day, so we act with urgency.
SPEAKER_02Art is long, life is short. The deadline is what forces you to do the work.
SPEAKER_00Exactly. The deadline forces the action. So here's the philosophical question. If you know with relative medical certainty that you have decades and decades of healthy, vibrant, pain-free life stretching out ahead of you, does your psychological drive fundamentally change? Does the urgency of life disappear? Do we become a society of procrastinators, becoming complacent because there's always tomorrow or next decade to write that book or change careers?
SPEAKER_02That's a dark thought, like we just lose our fire.
SPEAKER_00Or conversely, does removing the subconscious terror of physical decline and death finally free you? Does taking away the anxiety of a failing body allow you to truly live, to take massive risks, to learn a fifth language, to start over completely at age 70 without fear? Does it unlock a completely new phase of human potential that we haven't even evolved to understand yet?
SPEAKER_02Wow. If the biological scaffolding holds up and suddenly we have a clear, realistic path to a hundred or a hundred and twenty healthy functional years, what do we actually do all that time? Who do we become? That is something for you to chew on until next time.